[Malignant goiter--thyroid cancer].
D018263:Adenocarcinoma, Follicular / Q000175:diagnosis* / Q000628:therapy; D000328:Adult; D000359:Aftercare / Q000379:methods; D002116:Calcitonin / Q000097:blood; D002291:Carcinoma, Papillary / Q000175:diagnosis* / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D000075202:Contraindications; D003937:Diagnosis, Differential; D005260:Female; D006044:Goiter, Nodular / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use; D008197:Lymph Node Excision; D009367:Neoplasm Staging; D011379:Prognosis; D011877:Radionuclide Imaging; D018714:Radiotherapy, Adjuvant; D013961:Thyroid Gland / Q000000981:diagnostic imaging / Q000473:pathology; D013964:Thyroid Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D013965:Thyroidectomy; D013972:Thyrotropin / Q000627:therapeutic use; D014463:Ultrasonography
D007457:Iodine Radioisotopes; D013972:Thyrotropin; D002116:Calcitonin
Struma maligna--Schilddrüsenkarzinome.